Icon

Zynex Inc Stock Analysis and Price Target COMMON STOCK | Medical Distribution | NSD

stockTargetAdvisor

Hold

Average User
Rating
stockTargetAdvisor

Strong Buy

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis

USD 10.99

0.00 (0.00)%

USD 0.40B

0.15M

USD 15.38(+39.90%)

USD 11.00 (+0.09%)

Icon

ZYXI

Zynex Inc (USD)
COMMON STOCK | NSD
USD 10.99
0.00 0
stockTargetAdvisor

Hold

Average User
Rating
stockTargetAdvisor

Strong Buy

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis

USD 0.40B

USD 11.00 (+0.09%)

USD 10.99

Zynex Inc Stock Forecast

USD 15.38
(+39.90%)

Based on the Zynex Inc stock forecasts from 3 analysts, the average analyst target price for Zynex Inc is USD 15.38 over the next 12 months. Zynex Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Zynex Inc is Slightly Bullish , which is based on 10 positive signals and 6 negative signals. At the last closing, Zynex Inc’s stock price was USD 10.99. Zynex Inc’s stock price has changed by +4.67% over the past week, -14.27% over the past month and +73.89% over the last year.

No recent analyst target price found for Zynex Inc
No recent average analyst rating found for Zynex Inc

Company Overview

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality i...Read More

https://www.zynex.com

9655 Maroon Circle, Englewood, CO, United States, 80112

900

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Zynex Inc (Sector: Medical Distribution )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HSIC
Henry Schein Inc 0.00 (0.00%) USD10.30B 19.76 11.35

ETFs Containing ZYXI

Symbol Name Weight Mer Price(Change) Market Cap
BFOR
Barron's 400 ETF 0.00 % 0.65 % 0.00 (0.00%) USD0.12B

Frequently Asked Questions About ZYXI Stock

Based on ratings from 3 analysts Zynex Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 2 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ZYXI's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ZYXI is USD 15.38 over the next 12 months. The maximum analyst target price is USD 21 while the minimum anlayst target price is USD 10.

ZYXI stock's Price/Earning ratio is 24.42. Our analysis grades ZYXI stock's Price / Earning ratio at F. This means that ZYXI stock's Price/Earning ratio is above 67% of the stocks in the Medical Distribution sector in the NSD exchange. Based on this ZYXI may be a overvalued for its sector.

The last closing price of ZYXI's stock was USD 10.99.

The most recent market capitalization for ZYXI is USD 0.40B.

Based on targets from 3 analysts, the average taret price for ZYXI is projected at USD 15.38 over the next 12 months. This means that ZYXI's stock price may go up by +39.90% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...